A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma is a research paper published in The Oncologist (2024). On theSindex it has a DataRank of 1.4. It has been cited 46 times, with 45 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.578
From this paper's citation signal
Citation Network Contribution
0.784
From 27 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 45 citers.
National Institutes of Health
Grant: 5T32GM086330-08
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
NCI NIH HHS
Grant: K08 CA259342
NIGMS NIH HHS
Grant: T32 GM086330
FWCI
10.78
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals